Skip to main content
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1994 Sep 1;151(5):518.

The author responds

Ellen R Wiebe
PMCID: PMC1337183

Full text

PDF

Page 518

518

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Creinin M. D., Darney P. D. Methotrexate and misoprostol for early abortion. Contraception. 1993 Oct;48(4):339–348. doi: 10.1016/0010-7824(93)90079-m. [DOI] [PubMed] [Google Scholar]
  2. Kozlowski R. D., Steinbrunner J. V., MacKenzie A. H., Clough J. D., Wilke W. S., Segal A. M. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med. 1990 Jun;88(6):589–592. doi: 10.1016/0002-9343(90)90522-f. [DOI] [PubMed] [Google Scholar]
  3. Ross G. T. Congenital anomalies among children born of mothers receiving chemotherapy for gestational trophoblastic neoplasms. Cancer. 1976 Feb;37(2 Suppl):1043–1047. doi: 10.1002/1097-0142(197602)37:2+<1043::aid-cncr2820370809>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  4. Stovall T. G., Ling F. W., Buster J. E. Reproductive performance after methotrexate treatment of ectopic pregnancy. Am J Obstet Gynecol. 1990 Jun;162(6):1620–1624. doi: 10.1016/0002-9378(90)90928-z. [DOI] [PubMed] [Google Scholar]
  5. Stovall T. G., Ling F. W. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol. 1993 Jun;168(6 Pt 1):1759–1765. doi: 10.1016/0002-9378(93)90687-e. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES